Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Development of a rapid functional assay that predicts GLUT1 disease severity.

Zaman SM, Mullen SA, Petrovski S, Maljevic S, Gazina EV, Phillips AM, Jones GD, Hildebrand MS, Damiano J, Auvin S, Lerche H, Weber YG, Berkovic SF, Scheffer IE, Reid CA, Petrou S.

Neurol Genet. 2018 Dec 6;4(6):e297. doi: 10.1212/NXG.0000000000000297. eCollection 2018 Dec.

2.

Recommendations for the design of therapeutic trials for neonatal seizures.

Soul JS, Pressler R, Allen M, Boylan G, Rabe H, Portman R, Hardy P, Zohar S, Romero K, Tseng B, Bhatt-Mehta V, Hahn C, Denne S, Auvin S, Vinks A, Lantos J, Marlow N, Davis JM; International Neonatal Consortium.

Pediatr Res. 2018 Dec 24. doi: 10.1038/s41390-018-0242-2. [Epub ahead of print] Review.

PMID:
30584262
3.

Methodologic recommendations and possible interpretations of video-EEG recordings in immature rodents used as experimental controls: A TASK1-WG2 report of the ILAE/AES Joint Translational Task Force.

Akman O, Raol YH, Auvin S, Cortez MA, Kubova H, de Curtis M, Ikeda A, Dudek FE, Galanopoulou AS.

Epilepsia Open. 2018 Oct 11;3(4):437-459. doi: 10.1002/epi4.12262. eCollection 2018 Dec.

4.

Systematic review of the screening, diagnosis, and management of ADHD in children with epilepsy. Consensus paper of the Task Force on Comorbidities of the ILAE Pediatric Commission.

Auvin S, Wirrell E, Donald KA, Berl M, Hartmann H, Valente KD, Van Bogaert P, Cross JH, Osawa M, Kanemura H, Aihara M, Guerreiro MM, Samia P, Vinayan KP, Smith ML, Carmant L, Kerr M, Hermann B, Dunn D, Wilmshurst JM.

Epilepsia. 2018 Oct;59(10):1867-1880. doi: 10.1111/epi.14549. Epub 2018 Sep 3.

PMID:
30178479
5.

Ketogenic diet therapies in France: State of the use in 2018.

Dozières-Puyravel B, François L, de Lucia S, Goujon E, Danse M, Auvin S.

Epilepsy Behav. 2018 Sep;86:204-206. doi: 10.1016/j.yebeh.2018.05.031. Epub 2018 Jul 8.

PMID:
29997039
6.

Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.

Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Cross JH, Dahlin MG, Donner EJ, Guzel O, Jehle RS, Klepper J, Kang HC, Lambrechts DA, Liu YMC, Nathan JK, Nordli DR Jr, Pfeifer HH, Rho JM, Scheffer IE, Sharma S, Stafstrom CE, Thiele EA, Turner Z, Vaccarezza MM, van der Louw EJTM, Veggiotti P, Wheless JW, Wirrell EC; Charlie Foundation; Matthew's Friends; Practice Committee of the Child Neurology Society.

Epilepsia Open. 2018 May 21;3(2):175-192. doi: 10.1002/epi4.12225. eCollection 2018 Jun.

7.

Electro-behavioral phenotype and cell injury following exposure to paraoxon-ethyl in mice: Effect of the genetic background.

Baccus B, Auvin S, Dorandeu F.

Chem Biol Interact. 2018 Jun 25;290:119-125. doi: 10.1016/j.cbi.2018.05.009. Epub 2018 May 22.

PMID:
29800574
8.

The Problem of Rarity: Estimation of Prevalence in Rare Disease.

Auvin S, Irwin J, Abi-Aad P, Battersby A.

Value Health. 2018 May;21(5):501-507. doi: 10.1016/j.jval.2018.03.002. Epub 2018 Apr 5.

9.

Early identification of epileptic encephalopathy with continuous spikes-and-waves during sleep: A case-control study.

Desprairies C, Dozières-Puyravel B, Ilea A, Bellavoine V, Nasser H, Delanöe C, Auvin S.

Eur J Paediatr Neurol. 2018 Sep;22(5):837-844. doi: 10.1016/j.ejpn.2018.04.009. Epub 2018 Apr 27.

PMID:
29739701
10.

Abnormal white matter: Expanding the GLUT1-D phenotype.

Auvin S.

Eur J Paediatr Neurol. 2018 May;22(3):345. doi: 10.1016/j.ejpn.2018.03.007. No abstract available.

PMID:
29653610
11.

A common language of seizures and epilepsies: International League Against Epilepsy 2017 classifications.

Auvin S.

Dev Med Child Neurol. 2018 Apr;60(4):329. doi: 10.1111/dmcn.13694. No abstract available.

PMID:
29574712
12.

Prediction of responders to ketogenic diet based on syndrome and etiology: identification of a new target population?

Auvin S.

Dev Med Child Neurol. 2018 Jul;60(7):644. doi: 10.1111/dmcn.13755. Epub 2018 Mar 22. No abstract available.

PMID:
29569232
13.

Altered vaccine-induced immunity in children with Dravet syndrome.

Auvin S, Jeljeli M, Desnous B, Soussi-Yanicostas N, Dournaud P, Sterkers G.

Epilepsia. 2018 Apr;59(4):e45-e50. doi: 10.1111/epi.14038. Epub 2018 Mar 7.

PMID:
29512885
14.

Development and content validation of a preliminary core set of patient- and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome.

Nabbout R, Auvin S, Chiron C, Irwin J, Mistry A, Bonner N, Williamson N, Bennett B.

Epilepsy Behav. 2018 Jan;78:232-242. doi: 10.1016/j.yebeh.2017.08.029. Epub 2017 Nov 4.

15.

High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies.

Hamdan FF, Myers CT, Cossette P, Lemay P, Spiegelman D, Laporte AD, Nassif C, Diallo O, Monlong J, Cadieux-Dion M, Dobrzeniecka S, Meloche C, Retterer K, Cho MT, Rosenfeld JA, Bi W, Massicotte C, Miguet M, Brunga L, Regan BM, Mo K, Tam C, Schneider A, Hollingsworth G; Deciphering Developmental Disorders Study, FitzPatrick DR, Donaldson A, Canham N, Blair E, Kerr B, Fry AE, Thomas RH, Shelagh J, Hurst JA, Brittain H, Blyth M, Lebel RR, Gerkes EH, Davis-Keppen L, Stein Q, Chung WK, Dorison SJ, Benke PJ, Fassi E, Corsten-Janssen N, Kamsteeg EJ, Mau-Them FT, Bruel AL, Verloes A, Õunap K, Wojcik MH, Albert DVF, Venkateswaran S, Ware T, Jones D, Liu YC, Mohammad SS, Bizargity P, Bacino CA, Leuzzi V, Martinelli S, Dallapiccola B, Tartaglia M, Blumkin L, Wierenga KJ, Purcarin G, O'Byrne JJ, Stockler S, Lehman A, Keren B, Nougues MC, Mignot C, Auvin S, Nava C, Hiatt SM, Bebin M, Shao Y, Scaglia F, Lalani SR, Frye RE, Jarjour IT, Jacques S, Boucher RM, Riou E, Srour M, Carmant L, Lortie A, Major P, Diadori P, Dubeau F, D'Anjou G, Bourque G, Berkovic SF, Sadleir LG, Campeau PM, Kibar Z, Lafrenière RG, Girard SL, Mercimek-Mahmutoglu S, Boelman C, Rouleau GA, Scheffer IE, Mefford HC, Andrade DM, Rossignol E, Minassian BA, Michaud JL.

Am J Hum Genet. 2017 Nov 2;101(5):664-685. doi: 10.1016/j.ajhg.2017.09.008.

16.

Expert Opinion on the Management of Lennox-Gastaut Syndrome: Treatment Algorithms and Practical Considerations.

Cross JH, Auvin S, Falip M, Striano P, Arzimanoglou A.

Front Neurol. 2017 Sep 29;8:505. doi: 10.3389/fneur.2017.00505. eCollection 2017. Review.

17.

Functional ultrasound imaging of brain activity in human newborns.

Demene C, Baranger J, Bernal M, Delanoe C, Auvin S, Biran V, Alison M, Mairesse J, Harribaud E, Pernot M, Tanter M, Baud O.

Sci Transl Med. 2017 Oct 11;9(411). pii: eaah6756. doi: 10.1126/scitranslmed.aah6756.

PMID:
29021168
18.

[Evaluating a child after a febrile seizure: Insights on three important issues].

Auvin S, Antonios M, Benoist G, Dommergues MA, Corrard F, Gajdos V, Gras Leguen C, Launay E, Salaün A, Titomanlio L, Vallée L, Milh M.

Arch Pediatr. 2017 Nov;24(11):1137-1146. doi: 10.1016/j.arcped.2017.08.018. Epub 2017 Sep 29. French.

PMID:
28965695
19.

Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study.

Nikanorova M, Brandt C, Auvin S, McMurray R.

Epilepsy Behav. 2017 Nov;76:63-70. doi: 10.1016/j.yebeh.2017.08.026. Epub 2017 Sep 15.

PMID:
28927712
20.

[Therapeutic management of neonatal arterial cerebral infarction and neuroprotection perspectives].

Baud O, Auvin S, Saliba E, Biran V.

Arch Pediatr. 2017 Sep;24(9S):9S46-9S50. doi: 10.1016/S0929-693X(17)30331-7. French.

PMID:
28867038
21.

Anti-ictogenic and antiepileptogenic properties of perampanel in mature and immature rats.

Dupuis N, Enderlin J, Thomas J, Desnous B, Dournaud P, Allorge D, Auvin S.

Epilepsia. 2017 Nov;58(11):1985-1992. doi: 10.1111/epi.13894. Epub 2017 Aug 29.

22.

Use of perampanel in children and adolescents with Lennox-Gastaut Syndrome.

Auvin S, Dozieres B, Ilea A, Delanoë C.

Epilepsy Behav. 2017 Sep;74:59-63. doi: 10.1016/j.yebeh.2017.05.036. Epub 2017 Jul 14.

PMID:
28715780
23.

Non-ketogenic combination of nutritional strategies provides robust protection against seizures.

Dallérac G, Moulard J, Benoist JF, Rouach S, Auvin S, Guilbot A, Lenoir L, Rouach N.

Sci Rep. 2017 Jul 14;7(1):5496. doi: 10.1038/s41598-017-05542-3.

24.

Clinical studies and anti-inflammatory mechanisms of treatments.

French JA, Koepp M, Naegelin Y, Vigevano F, Auvin S, Rho JM, Rosenberg E, Devinsky O, Olofsson PS, Dichter MA.

Epilepsia. 2017 Jul;58 Suppl 3:69-82. doi: 10.1111/epi.13779.

25.

Prospective clinical trials to investigate clinical and molecular biomarkers.

Auvin S, Walker L, Gallentine W, Jozwiak S, Tombini M, Sills GJ.

Epilepsia. 2017 Jul;58 Suppl 3:20-26. doi: 10.1111/epi.13782. Review.

26.

Role of seizure in neonatal stroke.

Auvin S, Charriaut-Marlangue C.

Oncotarget. 2017 Jul 25;8(30):48531-48532. doi: 10.18632/oncotarget.18212. No abstract available.

27.

A simple blood test expedites the diagnosis of glucose transporter type 1 deficiency syndrome.

Gras D, Cousin C, Kappeler C, Fung CW, Auvin S, Essid N, Chung BH, Da Costa L, Hainque E, Luton MP, Petit V, Vuillaumier-Barrot S, Boespflug-Tanguy O, Roze E, Mochel F.

Ann Neurol. 2017 Jul;82(1):133-138. doi: 10.1002/ana.24970.

28.

Myoclonic jerks are commonly associated with absence seizures in early-onset absence epilepsy.

Nasser H, Lopez-Hernandez E, Ilea A, Le Morvan N, Bellavoine V, Delanoë C, Auvin S.

Epileptic Disord. 2017 Jun 1;19(2):137-146. doi: 10.1684/epd.2017.0905.

29.

Human Herpesvirus 6 (HHV-6) necrotizing encephalitis, a rare condition in immunocompromised patients: The importance of brain biopsy associated with HHV-6 testing.

Le Guennec L, Mokhtari K, Chauvet D, Dupuis N, Roos-Weil D, Agut H, Leclercq D, Psimaras D, Mayaux J, Demeret S, Choquet S, Auvin S, Bonnafous P, Gautheret-Dejean A, Weiss N.

J Neurol Sci. 2017 Jun 15;377:112-115. doi: 10.1016/j.jns.2017.04.003. Epub 2017 Apr 6. No abstract available.

PMID:
28477677
30.

Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.

Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, Lesca G, Ville D, Milh M, Villard L, Afenjar A, Chantot-Bastaraud S, Mignot C, Lardennois C, Nava C, Schwarz N, Gérard M, Perrin L, Doummar D, Auvin S, Miranda MJ, Hempel M, Brilstra E, Knoers N, Verbeek N, van Kempen M, Braun KP, Mancini G, Biskup S, Hörtnagel K, Döcker M, Bast T, Loddenkemper T, Wong-Kisiel L, Baumeister FM, Fazeli W, Striano P, Dilena R, Fontana E, Zara F, Kurlemann G, Klepper J, Thoene JG, Arndt DH, Deconinck N, Schmitt-Mechelke T, Maier O, Muhle H, Wical B, Finetti C, Brückner R, Pietz J, Golla G, Jillella D, Linnet KM, Charles P, Moog U, Õiglane-Shlik E, Mantovani JF, Park K, Deprez M, Lederer D, Mary S, Scalais E, Selim L, Van Coster R, Lagae L, Nikanorova M, Hjalgrim H, Korenke GC, Trivisano M, Specchio N, Ceulemans B, Dorn T, Helbig KL, Hardies K, Stamberger H, de Jonghe P, Weckhuysen S, Lemke JR, Krägeloh-Mann I, Helbig I, Kluger G, Lerche H, Møller RS.

Brain. 2017 May 1;140(5):1316-1336. doi: 10.1093/brain/awx054.

PMID:
28379373
31.

Efficacy of a ketogenic diet in resistant myoclono-astatic epilepsy: A French multicenter retrospective study.

Stenger E, Schaeffer M, Cances C, Motte J, Auvin S, Ville D, Maurey H, Nabbout R, de Saint-Martin A.

Epilepsy Res. 2017 Mar;131:64-69. doi: 10.1016/j.eplepsyres.2017.02.005. Epub 2017 Feb 20.

PMID:
28273610
32.

Different response to antiepileptic drugs according to the type of epileptic events in a neonatal ischemia-reperfusion model.

Morin L, Enderlin J, Leger PL, Perrotte G, Bonnin P, Dupuis N, Baud O, Charriaut-Marlangue C, Auvin S.

Neurobiol Dis. 2017 Mar;99:145-153. doi: 10.1016/j.nbd.2016.12.023. Epub 2016 Dec 30.

PMID:
28042096
33.

[Neonatal arterial ischemic stroke: Review of the current guidelines].

Saliba E, Debillon T; Recommandations accident vasculaire cérébral (AVC) néonatal, Auvin S, Baud O, Biran V, Chabernaud JL, Chabrier S, Cneude F, Cordier AG, Darmency-Stamboul V, Diependaele JF, Debillon T, Dinomais M, Durand C, Ego A, Favrais G, Gruel Y, Hertz-Pannier L, Husson B, Marret S, N'Guyen The Tich S, Perez T, Saliba E, Valentin JB, Vuillerot C.

Arch Pediatr. 2017 Feb;24(2):180-188. doi: 10.1016/j.arcped.2016.11.005. Epub 2016 Dec 20. French.

PMID:
28011082
34.

Pro-epileptogenic effects of viral-like inflammation in both mature and immature brains.

Dupuis N, Mazarati A, Desnous B, Chhor V, Fleiss B, Le Charpentier T, Lebon S, Csaba Z, Gressens P, Dournaud P, Auvin S.

J Neuroinflammation. 2016 Dec 12;13(1):307.

35.

Autosomal-Recessive Mutations in AP3B2, Adaptor-Related Protein Complex 3 Beta 2 Subunit, Cause an Early-Onset Epileptic Encephalopathy with Optic Atrophy.

Assoum M, Philippe C, Isidor B, Perrin L, Makrythanasis P, Sondheimer N, Paris C, Douglas J, Lesca G, Antonarakis S, Hamamy H, Jouan T, Duffourd Y, Auvin S, Saunier A, Begtrup A, Nowak C, Chatron N, Ville D, Mireskandari K, Milani P, Jonveaux P, Lemeur G, Milh M, Amamoto M, Kato M, Nakashima M, Miyake N, Matsumoto N, Masri A, Thauvin-Robinet C, Rivière JB, Faivre L, Thevenon J.

Am J Hum Genet. 2016 Dec 1;99(6):1368-1376. doi: 10.1016/j.ajhg.2016.10.009. Epub 2016 Nov 23.

36.

[Childhood absence epilepsy: An update].

Garzon P, Lemelle L, Auvin S.

Arch Pediatr. 2016 Nov;23(11):1176-1183. doi: 10.1016/j.arcped.2016.08.005. Epub 2016 Sep 24. Review. French.

PMID:
27683026
37.

Ketogenic diet guidelines for infants with refractory epilepsy.

van der Louw E, van den Hurk D, Neal E, Leiendecker B, Fitzsimmon G, Dority L, Thompson L, Marchió M, Dudzińska M, Dressler A, Klepper J, Auvin S, Cross JH.

Eur J Paediatr Neurol. 2016 Nov;20(6):798-809. doi: 10.1016/j.ejpn.2016.07.009. Epub 2016 Jul 17. Review.

PMID:
27470655
38.

A microRNA-328 binding site in PAX6 is associated with centrotemporal spikes of rolandic epilepsy.

Panjwani N, Wilson MD, Addis L, Crosbie J, Wirrell E, Auvin S, Caraballo RH, Kinali M, McCormick D, Oren C, Taylor J, Trounce J, Clarke T, Akman CI, Kugler SL, Mandelbaum DE, McGoldrick P, Wolf SM, Arnold P, Schachar R, Pal DK, Strug LJ.

Ann Clin Transl Neurol. 2016 Jun 2;3(7):512-22. doi: 10.1002/acn3.320. eCollection 2016 Jul.

39.

Use of modified Atkins diet in glucose transporter type 1 deficiency syndrome.

Amalou S, Gras D, Ilea A, Greneche MO, Francois L, Bellavoine V, Delanoe C, Auvin S.

Dev Med Child Neurol. 2016 Nov;58(11):1193-1199. doi: 10.1111/dmcn.13167. Epub 2016 Jun 8.

40.

Advancing pharmacologic treatment options for pharmacologic treatment options for children with epilepsy.

Auvin S.

Expert Opin Pharmacother. 2016 Aug;17(11):1475-82. doi: 10.1080/14656566.2016.1195809. Epub 2016 Jun 15. Review.

PMID:
27249542
41.

ADHD in childhood epilepsy: Clinical determinants of severity and of the response to methylphenidate.

Rheims S, Herbillon V, Villeneuve N, Auvin S, Napuri S, Cances C, Berquin P, Castelneau P, Nguyen The Tich S, Villega F, Isnard H, Nabbout R, Gaillard S, Mercier C, Kassai B, Arzimanoglou A; investigators of the Paediatric Epilepsy REsearch NEtwork (PERENE).

Epilepsia. 2016 Jul;57(7):1069-77. doi: 10.1111/epi.13420. Epub 2016 May 29.

42.

An unfortunate challenge: Ketogenic diet for the treatment of Lennox-Gastaut syndrome in tyrosinemia type 1.

De Lucia S, Pichard S, Ilea A, Greneche MO, François L, Delanoë C, Schiff M, Auvin S.

Eur J Paediatr Neurol. 2016 Jul;20(4):674-7. doi: 10.1016/j.ejpn.2016.02.015. Epub 2016 Mar 16.

PMID:
27052529
43.

Epilepsy diagnostic and treatment needs identified with a collaborative database involving tertiary centers in France.

Chipaux M, Szurhaj W, Vercueil L, Milh M, Villeneuve N, Cances C, Auvin S, Chassagnon S, Napuri S, Allaire C, Derambure P, Marchal C, Caubel I, Ricard-Mousnier B, N'Guyen The Tich S, Pinard JM, Bahi-Buisson N, de Baracé C, Kahane P, Gautier A, Hamelin S, Coste-Zeitoun D, Rosenberg SD, Clerson P, Nabbout R, Kuchenbuch M, Picot MC, Kaminska A; GRENAT Group.

Epilepsia. 2016 May;57(5):757-69. doi: 10.1111/epi.13368. Epub 2016 Apr 1.

44.

Non-pharmacological medical treatment in pediatric epilepsies.

Auvin S.

Rev Neurol (Paris). 2016 Mar;172(3):182-5. doi: 10.1016/j.neurol.2015.12.009. Epub 2016 Mar 15. Review.

PMID:
26993568
45.

Current understanding and neurobiology of epileptic encephalopathies.

Auvin S, Cilio MR, Vezzani A.

Neurobiol Dis. 2016 Aug;92(Pt A):72-89. doi: 10.1016/j.nbd.2016.03.007. Epub 2016 Mar 16. Review.

PMID:
26992889
46.

Retrospective evaluation of low long-term efficacy of antiepileptic drugs and ketogenic diet in 39 patients with CDKL5-related epilepsy.

Müller A, Helbig I, Jansen C, Bast T, Guerrini R, Jähn J, Muhle H, Auvin S, Korenke GC, Philip S, Keimer R, Striano P, Wolf NI, Püst B, Thiels Ch, Fogarasi A, Waltz S, Kurlemann G, Kovacevic-Preradovic T, Ceulemans B, Schmitt B, Philippi H, Tarquinio D, Buerki S, von Stülpnagel C, Kluger G.

Eur J Paediatr Neurol. 2016 Jan;20(1):147-51. doi: 10.1016/j.ejpn.2015.09.001. Epub 2015 Sep 10.

PMID:
26387070
47.

Trans-Modulation of the Somatostatin Type 2A Receptor Trafficking by Insulin-Regulated Aminopeptidase Decreases Limbic Seizures.

De Bundel D, Fafouri A, Csaba Z, Loyens E, Lebon S, El Ghouzzi V, Peineau S, Vodjdani G, Kiagiadaki F, Aourz N, Coppens J, Walrave L, Portelli J, Vanderheyden P, Chai SY, Thermos K, Bernard V, Collingridge G, Auvin S, Gressens P, Smolders I, Dournaud P.

J Neurosci. 2015 Aug 26;35(34):11960-75. doi: 10.1523/JNEUROSCI.0476-15.2015.

48.

[Objectives and practical aspects of antiepileptic medication].

Auvin S.

Soins Pediatr Pueric. 2015 Mar-Apr;(283):19-21. doi: 10.1016/j.spp.2015.01.003. French.

PMID:
26100479
49.

Ketogenic diet exhibits anti-inflammatory properties.

Dupuis N, Curatolo N, Benoist JF, Auvin S.

Epilepsia. 2015 Jul;56(7):e95-8. doi: 10.1111/epi.13038. Epub 2015 May 23.

50.

Anti-ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats.

Dupuis N, Matagne A, Staelens L, Dournaud P, Desnous B, Gressens P, Auvin S.

Epilepsia. 2015 May;56(5):800-5. doi: 10.1111/epi.12973. Epub 2015 Mar 25.

Supplemental Content

Support Center